Brief: CSL Says Neffy, Adrenaline Nasal Spray, Approved To Treat Anaphylaxis In Australia
16/02/2026 01:57
Feb 16 (Reuters) - CSL Ltd CSL.AX: NEFFY, ADRENALINE NASAL SPRAY, NOW APPROVED TO TREAT ANAPHYLAXIS IN AUSTRALIA Further company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX